Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1996 Feb 1;97(3):879–883. doi: 10.1172/JCI118490

Increased acetyl group availability enhances contractile function of canine skeletal muscle during ischemia.

J A Timmons 1, S M Poucher 1, D Constantin-Teodosiu 1, V Worrall 1, I A Macdonald 1, P L Greenhaff 1
PMCID: PMC507129  PMID: 8609248

Abstract

Skeletal muscle contractile function is impaired during acute ischemia such as that experienced by peripheral vascular disease patients. We therefore, examined the effects of dichloroacetate, which can alter resting metabolism, on canine gracilis muscle contractile function during constant flow ischemia. Pretreatment with dichloroacetate increased resting pyruvate dehydrogenase complex activity and resting acetylcarnitine concentration by approximately 4- and approximately 10-fold, respectively. After 20-min contraction the control group had demonstrated an approximately 40% reduction in isomeric tension whereas the dichloroacetate group had fatigued by approximately 25% (P < 0.05). Dichloroacetate resulted in less lactate accumulation (10.3 +/- 3.0 vs 58.9 +/- 10.5 mmol.kg-1 dry muscle [dm], P < 0.05) and phosphocreatine hydrolysis (15.6 +/- 6.3 vs 33.8 +/- 9.0 mmol.kg-1 dm, P < 0.05) during contraction. Acetylcarnitine concentration fell during contraction by 5.4 +/- 1.8 mmol.kg-1 dm in the dichloroacetate group but increased by 10.0 +/- 1.9 mmol.kg-1 dm in the control group. In conclusion, dichloroacetate enhanced contractile function during ischemia, independently of blood flow, such that it appears oxidative ATP regeneration is limited by pyruvate dehydrogenase complex activity and acetyl group availability.

Full Text

The Full Text of this article is available as a PDF (155.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barclay J. K. A delivery-independent blood flow effect on skeletal muscle fatigue. J Appl Physiol (1985) 1986 Sep;61(3):1084–1090. doi: 10.1152/jappl.1986.61.3.1084. [DOI] [PubMed] [Google Scholar]
  2. Bergstrom J. Percutaneous needle biopsy of skeletal muscle in physiological and clinical research. Scand J Clin Lab Invest. 1975 Nov;35(7):609–616. [PubMed] [Google Scholar]
  3. Bersin R. M., Wolfe C., Kwasman M., Lau D., Klinski C., Tanaka K., Khorrami P., Henderson G. N., de Marco T., Chatterjee K. Improved hemodynamic function and mechanical efficiency in congestive heart failure with sodium dichloroacetate. J Am Coll Cardiol. 1994 Jun;23(7):1617–1624. doi: 10.1016/0735-1097(94)90665-3. [DOI] [PubMed] [Google Scholar]
  4. Cederblad G., Carlin J. I., Constantin-Teodosiu D., Harper P., Hultman E. Radioisotopic assays of CoASH and carnitine and their acetylated forms in human skeletal muscle. Anal Biochem. 1990 Mar;185(2):274–278. doi: 10.1016/0003-2697(90)90292-h. [DOI] [PubMed] [Google Scholar]
  5. Constantin-Teodosiu D., Carlin J. I., Cederblad G., Harris R. C., Hultman E. Acetyl group accumulation and pyruvate dehydrogenase activity in human muscle during incremental exercise. Acta Physiol Scand. 1991 Dec;143(4):367–372. doi: 10.1111/j.1748-1716.1991.tb09247.x. [DOI] [PubMed] [Google Scholar]
  6. Constantin-Teodosiu D., Cederblad G., Hultman E. A sensitive radioisotopic assay of pyruvate dehydrogenase complex in human muscle tissue. Anal Biochem. 1991 Nov 1;198(2):347–351. doi: 10.1016/0003-2697(91)90437-x. [DOI] [PubMed] [Google Scholar]
  7. Constantin-Teodosiu D., Cederblad G., Hultman E. PDC activity and acetyl group accumulation in skeletal muscle during isometric contraction. J Appl Physiol (1985) 1993 Apr;74(4):1712–1718. doi: 10.1152/jappl.1993.74.4.1712. [DOI] [PubMed] [Google Scholar]
  8. Dyck D. J., Putman C. T., Heigenhauser G. J., Hultman E., Spriet L. L. Regulation of fat-carbohydrate interaction in skeletal muscle during intense aerobic cycling. Am J Physiol. 1993 Dec;265(6 Pt 1):E852–E859. doi: 10.1152/ajpendo.1993.265.6.E852. [DOI] [PubMed] [Google Scholar]
  9. Favero T. G., Zable A. C., Bowman M. B., Thompson A., Abramson J. J. Metabolic end products inhibit sarcoplasmic reticulum Ca2+ release and [3H]ryanodine binding. J Appl Physiol (1985) 1995 May;78(5):1665–1672. doi: 10.1152/jappl.1995.78.5.1665. [DOI] [PubMed] [Google Scholar]
  10. Fitts R. H. Cellular mechanisms of muscle fatigue. Physiol Rev. 1994 Jan;74(1):49–94. doi: 10.1152/physrev.1994.74.1.49. [DOI] [PubMed] [Google Scholar]
  11. Greenhaff P. L., Nevill M. E., Soderlund K., Bodin K., Boobis L. H., Williams C., Hultman E. The metabolic responses of human type I and II muscle fibres during maximal treadmill sprinting. J Physiol. 1994 Jul 1;478(Pt 1):149–155. doi: 10.1113/jphysiol.1994.sp020238. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Harris R. C., Hultman E., Nordesjö L. O. Glycogen, glycolytic intermediates and high-energy phosphates determined in biopsy samples of musculus quadriceps femoris of man at rest. Methods and variance of values. Scand J Clin Lab Invest. 1974 Apr;33(2):109–120. [PubMed] [Google Scholar]
  13. Higgins A. J., Morville M., Burges R. A., Blackburn K. J. Mechanism of action of oxfenicine on muscle metabolism. Biochem Biophys Res Commun. 1981 May 15;100(1):291–296. doi: 10.1016/s0006-291x(81)80095-2. [DOI] [PubMed] [Google Scholar]
  14. Hogan M. C., Gladden L. B., Kurdak S. S., Poole D. C. Increased [lactate] in working dog muscle reduces tension development independent of pH. Med Sci Sports Exerc. 1995 Mar;27(3):371–377. [PubMed] [Google Scholar]
  15. Hultman E., Bergström J., Anderson N. M. Breakdown and resynthesis of phosphorylcreatine and adenosine triphosphate in connection with muscular work in man. Scand J Clin Lab Invest. 1967;19(1):56–66. doi: 10.3109/00365516709093481. [DOI] [PubMed] [Google Scholar]
  16. Katz A., Broberg S., Sahlin K., Wahren J. Leg glucose uptake during maximal dynamic exercise in humans. Am J Physiol. 1986 Jul;251(1 Pt 1):E65–E70. doi: 10.1152/ajpendo.1986.251.1.E65. [DOI] [PubMed] [Google Scholar]
  17. Katz A., Sahlin K. Regulation of lactic acid production during exercise. J Appl Physiol (1985) 1988 Aug;65(2):509–518. doi: 10.1152/jappl.1988.65.2.509. [DOI] [PubMed] [Google Scholar]
  18. Lewandowski E. D., White L. T. Pyruvate dehydrogenase influences postischemic heart function. Circulation. 1995 Apr 1;91(7):2071–2079. doi: 10.1161/01.cir.91.7.2071. [DOI] [PubMed] [Google Scholar]
  19. Lundgren F., Bennegård K., Elander A., Lundholm K., Scherstén T., Bylund-Fellenius A. C. Substrate exchange in human limb muscle during exercise at reduced blood flow. Am J Physiol. 1988 Nov;255(5 Pt 2):H1156–H1164. doi: 10.1152/ajpheart.1988.255.5.H1156. [DOI] [PubMed] [Google Scholar]
  20. McVeigh J. J., Lopaschuk G. D. Dichloroacetate stimulation of glucose oxidation improves recovery of ischemic rat hearts. Am J Physiol. 1990 Oct;259(4 Pt 2):H1079–H1085. doi: 10.1152/ajpheart.1990.259.4.H1079. [DOI] [PubMed] [Google Scholar]
  21. Mjos O. D., Miller N. E., Riemersma R. A., Oliver M. F. Effects of dichloroacetate on myocardial substrate extraction, epicardial ST-segment elevation, and ventricular blood flow following coronary occlusion in dogs. Cardiovasc Res. 1976 Jul;10(4):427–436. doi: 10.1093/cvr/10.4.427. [DOI] [PubMed] [Google Scholar]
  22. Patel T. B., Olson M. S. Regulation of pyruvate dehydrogenase complex in ischemic rat heart. Am J Physiol. 1984 Jun;246(6 Pt 2):H858–H864. doi: 10.1152/ajpheart.1984.246.6.H858. [DOI] [PubMed] [Google Scholar]
  23. Putman C. T., Spriet L. L., Hultman E., Dyck D. J., Heigenhauser G. J. Skeletal muscle pyruvate dehydrogenase activity during acetate infusion in humans. Am J Physiol. 1995 May;268(5 Pt 1):E1007–E1017. doi: 10.1152/ajpendo.1995.268.5.E1007. [DOI] [PubMed] [Google Scholar]
  24. RANDLE P. J., GARLAND P. B., HALES C. N., NEWSHOLME E. A. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet. 1963 Apr 13;1(7285):785–789. doi: 10.1016/s0140-6736(63)91500-9. [DOI] [PubMed] [Google Scholar]
  25. Regensteiner J. G., Hiatt W. R. Exercise rehabilitation for patients with peripheral arterial disease. Exerc Sport Sci Rev. 1995;23:1–24. [PubMed] [Google Scholar]
  26. Stacpoole P. W. The pharmacology of dichloroacetate. Metabolism. 1989 Nov;38(11):1124–1144. doi: 10.1016/0026-0495(89)90051-6. [DOI] [PubMed] [Google Scholar]
  27. Zinker B. A., Namdaran K., Wilson R., Lacy D. B., Wasserman D. H. Acute adaptation of carbohydrate metabolism to decreased arterial PO2. Am J Physiol. 1994 Jun;266(6 Pt 1):E921–E929. doi: 10.1152/ajpendo.1994.266.6.E921. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES